title: From East to West: a Japanese Pharma perspective on establishing a global research capability.
abstract: Takeda (http://www.takeda.com) is one of the oldest Pharmaceutical companies in the world and has been the largest Japanese Pharmaceutical company for over a decade. Although many of its operations such as development and marketing have been conducted on a global basis for a number of years, research has historically been focused on in-house activities inside Japan, which have a successful track record in generating pioneer blockbuster drugs. To meet the ever-increasing challenge of maintaining a robust pipeline and a continuous stream of INDs, Takeda has embarked on a program to globalize its internal drug discovery capability through the integration of world-class research entities. We outline the strategies, opportunities and challenges of building a global research network from the perspective of a Japanese Pharmaceutical company.
authors.affiliation: Global Research Management, Pharmaceutical Research Department, Takeda Pharmaceutical Company, Yodogawa-Ku, Osaka, Japan.
authors.forename: Muneo
authors.initials: M
authors.lastname: Takatani
authors.forename: Barry
authors.initials: B
authors.lastname: Kenny
authors.forename: Nick
authors.initials: N
authors.lastname: Hird
mesh_terms: D000818:Animals; D035843:Biomedical Research / Q000379:methods / Q000639:trends*; D055808:Drug Discovery / Q000379:methods / Q000639:trends; D006801:Humans; D007391:International Cooperation; D007564:Japan; D013678:Technology, Pharmaceutical / Q000379:methods / Q000639:trends*